Ex vivo susceptibility to dihydroartemisinin in Plasmodium falciparum patient isolates from Eastern Rwanda, 2025. [PDF]
Oliveira R +13 more
europepmc +1 more source
Modeling the potential effect of cabamiquine-pyronaridine for chemoprevention against <i>Plasmodium falciparum</i> malaria. [PDF]
Okell LC +6 more
europepmc +1 more source
Association of Parasite Biomass with Disease Severity in Plasmodium vivax and Plasmodium falciparum Malaria Infections. [PDF]
Babar PH +13 more
europepmc +1 more source
First evidence of plasmodium falciparum-plasmodium ovale co-infection with delayed clinical presentation in an Ivorian patient: observations and diagnostic challenges. [PDF]
Akhoundi M, Guedri G, Brun S, Marteau A.
europepmc +1 more source
Cell cycle checkpoint activity in the malaria parasite <i>Plasmodium falciparum</i>. [PDF]
Johnson MK +4 more
europepmc +1 more source
Genetic analysis of pyrimidine biosynthetic enzymes in Plasmodium falciparum. [PDF]
Rajaram K +6 more
europepmc +1 more source
Association between thrombocytopaenia and Plasmodium falciparum infection in Ghana. [PDF]
Duneeh RV +7 more
europepmc +1 more source
Autoreactive and parasite-specific IgG repertoires in asymptomatic and mild Plasmodium falciparum infection in Côte d'Ivoire. [PDF]
Koffi D +7 more
europepmc +1 more source
Plasmodium falciparum antimalarial resistance in Angola: a systematic review. [PDF]
Matias D +7 more
europepmc +1 more source
<i>Plasmodium falciparum</i> putative Hsp90 functionally complements yeast Hsp90 and is inhibited in an isoform-specific manner. [PDF]
Khamitkar SR +5 more
europepmc +1 more source

